Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
- PMID: 11299055
- PMCID: PMC128891
- DOI: 10.1186/ar292
Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
Abstract
This paper reviews hypotheses about roles of angiogenesis in the pathogenesis of inflammatory disease in two organs, the synovial joint and the lung. Neovascularisation is a fundamental process for growth and tissue repair after injury. Nevertheless, it may contribute to a variety of chronic inflammatory diseases, including rheumatoid arthritis, osteoarthritis, asthma, and pulmonary fibrosis. Inflammation can promote angiogenesis, and new vessels may enhance tissue inflammation. Angiogenesis in inflammatory disease may also contribute to tissue growth, disordered tissue perfusion, abnormal ossification, and enhanced responses to normal or pathological stimuli. Angiogenesis inhibitors may reduce inflammation and may also help to restore appropriate tissue structure and function.
Figures
References
-
- Ballou SP, Kushner I. Laboratory evaluation of inflammation. In Textbook of Rheumatology Edited by Kelley WN, Harris ED Jr, Ruddy S, Sledge CB Philadelphia: W B Saunders Co, 2000. pp. 697–703.
-
- Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674. - PubMed
-
- Polverini PJ. Role of the macrophage in angiogenesis-dependent diseases. In Regulation of angiogenesis Edited by Goldberg ID, Rosen EM Berlin: Birkhauser, 1997. pp. 11–28. - PubMed
-
- Walsh DA. Angiogenesis and arthritis. Rheumatology (Oxford) 1999;38:103–112. - PubMed
-
- McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med. 2000;161:1877–1880. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
